Research Use Only - Not for human consumption. 18+ only.
DGrade DTheoretical or in-vitro only; no meaningful independent human evidenceResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use onlyMetabolic & Weight LossOral

5-Amino-1MQ

Also known as: 1MQ, 5-Amino-1-methylquinolinium

NNMT (nicotinamide N-methyltransferase) inhibitor that promotes fat loss by increasing NAD+ levels and enhancing cellular energy metabolism.

Beginner Basics

Plain-English guide to 5-Amino-1MQ

What it does

This compound works by blocking an enzyme in your cells that normally slows down energy production, allowing your cells to burn more fat and produce more energy. Researchers study it because it may help increase metabolism and support weight loss.

Typical dose

Researchers commonly use 50-100 mg taken once or twice daily by mouth, usually starting at the lower dose to see how your body responds.

When to inject

Take it in the morning or split the dose between morning and evening, ideally with food to help your body absorb it.

Storage

Keep the powder at room temperature (15-25°C) in a dry place away from light and moisture in its original container. Do not refrigerate unless the manufacturer says to.

First-timer tip

Start with 50 mg once per day for at least a week to see how your body tolerates it before increasing to twice daily, since research data in humans is still limited.

Research Status

DGrade DTheoretical or in-vitro only; no meaningful independent human evidenceResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only

Early Research

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Promotes fat loss and weight reduction
Increases metabolic rate and energy expenditure
Enhances NAD+ levels in cells
Supports mitochondrial function and biogenesis
May improve insulin sensitivity
Activates sirtuin-mediated metabolic pathways
Reduces adipose tissue accumulation

Side Effects

Gastrointestinal upset (nausea, mild stomach discomfort)
CommonMild

Often occurs when taken on an empty stomach. Mitigate by taking with food. Usually resolves within 1-2 weeks as tolerance develops.

Headache
UncommonMild

May occur during initial dosing. Ensure adequate hydration and consider dose reduction if persistent.

Insomnia or sleep disturbance
UncommonMild

Possible due to increased metabolic rate and NAD+ activation. Avoid dosing in late afternoon or evening; take morning dose only.

Increased heart rate or palpitations
UncommonModerate

May occur due to elevated metabolic rate. Monitor heart rate; discontinue and seek medical evaluation if severe or persistent.

Dizziness or lightheadedness
RareMild

May indicate dehydration or blood pressure changes. Ensure adequate fluid intake and monitor blood pressure.

Appetite suppression
CommonMild

Expected effect related to metabolic enhancement. Ensure adequate caloric and nutrient intake to support health.

Elevated liver enzymes (ALT/AST)
RareModerate

Reported in preclinical studies at high doses. Monitor liver function if using for extended periods; discontinue if enzymes become significantly elevated.

Dosing Reference

ParameterValue
Dose range50-100 mg
Frequency, timing and route - members only

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2-8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

5-Amino-1MQ inhibits NNMT, an enzyme that consumes NAD+ cofactors. By blocking NNMT activity, the compound increases intracellular NAD+ availability, which activates sirtuins and enhances mitochondrial function. This leads to increased energy expenditure, improved fat oxidation, and metabolic rate elevation.

Pathways and mechanism detail available to members

Track your 5-Amino-1MQ research

Free account. No credit card required.

Start Free

Recent Research

All results

Source: PubMed / NCBI. Updated daily. Articles are listed for research reference only.

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. 5-Amino-1MQ is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.